DA Davidson Maintains Neutral on Teladoc Health, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
DA Davidson analyst Gil Luria maintains a Neutral rating on Teladoc Health (TDOC) and lowers the price target from $22 to $18.
February 21, 2024 | 6:36 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DA Davidson analyst Gil Luria maintains a Neutral rating on Teladoc Health and lowers the price target from $22 to $18.
The reduction in price target by DA Davidson, a reputable financial firm, could lead to a negative short-term sentiment among investors, potentially causing a decrease in TDOC's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100